Various infections
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Exposure group: (1) Patients with clinical pharmacist consultation; (2) Patients whose consultation purpose is related to antimicrobial use; (3) Patients for whom the clinical pharmacist provides recommendations on antimicrobial dosing regimens; (4) Patients with complete clinical data; 2. Control group: (1) Patients without clinical pharmacist consultation; (2) Patients receiving antimicrobial therapy during the same period; (3) Patients with complete clinical data;
Exclusion criteria
Exclusion criteria: 1.Clinical data is incomplete; 2.Patients hospitalized for less than 24 hours; 3.Patients discharged or deceased within 48 hours after consultation; 4.The purpose of the consultation is clearly for patients applying for higher-level antibiotics or combination therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of treatment for infectious diseases;Rational use rate of antimicrobial drugs; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse drug reactions (ADR);In-hospital infection-related mortality;Antibiotic Costs (Yuan);Adoption rate of consultation opinions;Cumulative DDD of antimicrobial drugs; | — |
Countries
China
Contacts
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology